Page 1 2 ... 30 40 50 ... 200 ... NEXT>>
[ August 29, 2016 | Author: admin | Views: 44531 | Weather: | Mood: normal]

The ECB just announced a further reduction in interest rates, extended its QE program by increasing the rate at which buys assets, beefed up the TLTRO program and extended its horizon. It all sounds like good news and many of these actions had been expected in the last meeting of 2015 and they did not happen. Markets reacted very positively on announcement but later, after the press conference, they went down to levels that were significantly below where they were before the announcement. It is always hard to comment on why markets react in a certain way to monetary policy announcements but I must say that watching the press conference I learned about the state of desperation and possibly confusion of the ECB, which was not very reassuring. It might not be their fault, this is life when central banks hit the zero lower bound on interest rates and there … Continue reading

[ August 26, 2016 | Author: admin | Views: 41021 | Weather: | Mood: normal]

Related USO July Crude Oil Crosses $50 And Retreats Are The Markets 'Melting Up'? Niger Delta Avengers Strike Again – Oil Markets Daily (Seeking Alpha) Related DWTI Wall Street Not Surprised At Lack Of Weekend Agreement In Doha OPEC Production Cut Talks Sends Oil Surging Higher; Saudi Arabia Calling For 5% Cut? The Money Of Oil (Seeking Alpha) John Kilduff, a partner at Again Capital, has been negative on oil for quite some time and defended his thesis during an appearance on CNBC. Top Healthcare Equipment Companies To Own In Right Now: Imprivata, Inc.(IMPR)   Imprivata, Inc. provides information technology security and identity solutions to the healthcare industry in the United States, the United Kingdom, and internationally. Its security and identity platform provides authentication management, fast access to patient information, secure communication, and positive patient identification products to address critical security and compliance challenges faced by healthcare organizations. The company … Continue reading

[ August 26, 2016 | Author: admin | Views: 55430 | Weather: | Mood: normal]

Wolfe Research’s Scott Group and team aren’t worried too much about FedEx’s (FDX) earnings, which are scheduled to be released next Wednesday. They are worried about 2017, however. In a note released yesterday, they explain why: Zuma Press FedExwill report F3Q EPS on Wed. (3/16) and were lowering our EPS modestly to $2.27 vs. current Cons. of $2.35. We think expectations are low for FedExs report as mgmt has cautioned about a tough y/y fuel comp. However, winter weather was benign this year, jet fuel prices fell slightly sequentially, global airfreight vols have been a little stronger to begin the year, andFedEx has ramped up share buybacks. So we dont see as much risk of a large miss as we believe some expect… The Bigger Risk Could Be F17. Our reduced F16 EPS of $10.50 is still within FedExs guidance of $10.40-$10.90, so we thinkFedEx could keep its full-year view … Continue reading

[ August 26, 2016 | Author: admin | Views: 37328 | Weather: | Mood: normal]

Related EWZ The Brazilian Giver: Maranh茫o Goes Back On Rousseff's Impeachment Annulment Rousseff Impeachment Vote Surprisingly Annulled Gold Shines A Light On Dollar Weakness (Seeking Alpha) Related BRF The Brazilian Giver: Maranh茫o Goes Back On Rousseff's Impeachment Annulment Rousseff Impeachment Vote Surprisingly Annulled Bovespa: Fundamentals Are Very Fragile (Seeking Alpha) Fitch Ratings has been reviewing its stance on South America. Between last Thursday and this Monday, the firm decided to downgrade its rating on Brazil’s: Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDRs), from 'BB+' to 'BB,' keeping a Negative Outlook. Senior unsecured Foreign- and Local-Currency bonds, from 'BB+' to 'BB.' Country Ceiling, from 'BBB-' to 'BB+' Senior secured pass-through notes issued by Brazil Loan Trust I, from 'BB+sf' to 'BBsf,' issuing a Negative outlook. This applies to $661.9 million notes. In addition, analysts at Fitch downgraded six Brazilian subnationals this week. The Sao Paulo, Santa Catarina and Parana's States … Continue reading

[ August 25, 2016 | Author: admin | Views: 43598 | Weather: | Mood: normal]

Biotech stocks have climbed steadily higher over the past few weeks. Still, the iShares Nasdaq Biotechnology ETF (IBB) has remained range bound between $240 and $290 for much of 2016. So with major stock indices hitting new record highs, can biotech stocks break free? Perhaps, says Michael Yee, the industry analyst for RBC Capital Markets. But first, the market wants the political rhetoric surrounding drug prices to calm down, new positive clinical data and, finally, M&A activity. Weve said a HC rotation from well owned and big outperforming defensive lower risk yield stocks like med tech should eventually shift a bit into underperforming biotech but generalists feel no rush to do that and think we need visibility on an election and whether the political rhetoric on drug pricing will calm down after the general election is won. As PMs position for 2017, defensive outperformers in 2016 may not be the … Continue reading